Leading the Fight Against Fentanyl

Safe Supply (CSE: SPLY) – Securing Our Borders, Protecting Our Communities

 

America is facing a fentanyl crisis like never before. Deadly drugs are pouring across the border, devastating families and overwhelming communities. Safe Supply (CSE: SPLY) is on the front lines, delivering real solutions to detect and prevent fentanyl poisoning.

 

We are leading the charge with cutting-edge drug detection technology, ensuring law enforcement, businesses, and families have the tools to fight back. Our fentanyl and xylazine test strips, drink spike detection, and harm reduction initiatives are critical national security assets.

 

This is more than just a company—it’s a mission. Governments, institutions, and private sector leaders are waking up to the crisis, and Safe Supply is positioned to be the national leader in harm reduction technology.

 

We are building the future of safety, security, and prevention. The fentanyl epidemic is a trillion-dollar challenge, and Safe Supply is providing real solutions with real impact.

 

This is the company that gets it done. This is the fight that matters. Safe Supply is leading the way.

The Next Frontier in Healthcare: AI powered Innovation

From Diagnostics to Medical Technology:

AI is Leading the Next Healthcare Revolution

Improves accuracy and speed in disease detection.

Diagnostics & Medical Testing

Offers personalized mental health support using AI assisted feedback.

Mental Healthcare

Identify at-risk individuals and optimize harm reduction strategies, reducing the impact of chronic conditions and substance use.

Harm Reduction

Empowers individuals to proactively manage their health through personalized wellness programs and real-time monitoring.

Health & Wellness

Innovations drive the development of cutting-edge medical devices, improving the effectiveness of healthcare delivery.

Medical Technology

THIS IS GOING TO CREATE A

$1.7 Trillion+

total addressable market

is at the forefront of this opportunity.

Our CEO

Bill Panagiotakopoulos

"We are witnessing a significant shift towards innovative healthcare solutions to address public health challenges. In Canada alone, the impact of ineffective healthcare practices costs nearly $50 billion annually. By integrating medical technologies and AI-powered healthcare, we aim to achieve better health outcomes while significantly reducing societal costs, moving beyond traditional approaches that have proven costly and less effective."

In the news

Enter your details to download the investor presentation.